Jia Jie Biomedical Co Ltd (4109) - Total Liabilities

Latest as of September 2025: NT$159.28 Million TWD ≈ $5.02 Million USD

Based on the latest financial reports, Jia Jie Biomedical Co Ltd (4109) has total liabilities worth NT$159.28 Million TWD (≈ $5.02 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 4109 cash generation efficiency to assess how effectively this company generates cash.

Jia Jie Biomedical Co Ltd - Total Liabilities Trend (2015–2024)

This chart illustrates how Jia Jie Biomedical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 4109 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Jia Jie Biomedical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Jia Jie Biomedical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Zhengye Biotechnology Holding Limited Ordinary Shares NASDAQ:ZYBT	USA	$140.71 Million
Banswara Syntex Limited NSE:BANSWRAS	India	Rs6.99 Billion
Sarine Technologies Ltd TA:SARN	Israel	ILA13.21 Million
NH SPAC 5 KQ:215790	Korea	₩31.19 Billion
MIRA Pharmaceuticals, Inc. Common Stock NASDAQ:MIRA	USA	$83.93K
Ezwelfare Co Ltd KQ:090850	Korea	₩142.38 Billion

Liability Composition Analysis (2015–2024)

This chart breaks down Jia Jie Biomedical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Jia Jie Biomedical Co Ltd (4109) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.93	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.10	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.09	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jia Jie Biomedical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jia Jie Biomedical Co Ltd (2015–2024)

The table below shows the annual total liabilities of Jia Jie Biomedical Co Ltd from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	NT$123.08 Million ≈ $3.88 Million	-64.08%
2023-12-31	NT$342.69 Million ≈ $10.80 Million	+328.38%
2022-12-31	NT$80.00 Million ≈ $2.52 Million	-7.48%
2021-12-31	NT$86.47 Million ≈ $2.72 Million	+6.17%
2020-12-31	NT$81.44 Million ≈ $2.57 Million	-49.39%
2019-12-31	NT$160.92 Million ≈ $5.07 Million	-60.21%
2018-12-31	NT$404.40 Million ≈ $12.74 Million	-34.94%
2017-12-31	NT$621.58 Million ≈ $19.58 Million	-9.25%
2016-12-31	NT$684.91 Million ≈ $21.58 Million	+14.95%
2015-12-31	NT$595.84 Million ≈ $18.77 Million	--

About Jia Jie Biomedical Co Ltd

TWO:4109 Taiwan Packaged Foods

Market Cap

$43.58 Million

NT$1.38 Billion TWD

Market Cap Rank

#22378 Global

#1389 in Taiwan

Share Price

NT$11.65

Change (1 day)

+0.00%

52-Week Range

NT$11.45 - NT$18.10

All Time High

NT$36.47